MedPage Today 
(5/19, Kaiser) reported, "Catheter-based renal nerve ablation helps
lower resistant hypertension, but now researchers have found that it
works as well in those with chronic kidney disease (CKD)," according to a
study
published online May 17 in the Journal of the American Society of
Nephrology. "In 15 patients with resistant hypertension and stage 3 and
4 CKD, bilateral renal denervation lowered blood pressure by a mean of
34/14 mmHg at one
month and 32/15 mmHg at six months," researchers reported. "The mean
estimated glomerular filtration rate (eGFR) did not change after the
procedure, even though patients received contrast media for renal
catheterization or CO2 angiography," the study found.
(5/19, Kaiser) reported, "Catheter-based renal nerve ablation helps
lower resistant hypertension, but now researchers have found that it
works as well in those with chronic kidney disease (CKD)," according to a
study
published online May 17 in the Journal of the American Society of
Nephrology. "In 15 patients with resistant hypertension and stage 3 and
4 CKD, bilateral renal denervation lowered blood pressure by a mean of
34/14 mmHg at one
month and 32/15 mmHg at six months," researchers reported. "The mean
estimated glomerular filtration rate (eGFR) did not change after the
procedure, even though patients received contrast media for renal
catheterization or CO2 angiography," the study found.
Renal Denervation Systems May Help Reduce Hypertension.
MedPage Today
(5/19, Phend) reported, "Results of pilot studies on a variety of
novel renal sympathetic nerve ablation catheters are achieving in the
range of 28/10 to 32/15 mm Hg blood pressure reductions at one month,
researchers reported...at the EuroPCR meeting." In fact, "clinical
trials of the first such device -- the Symplicity single-electrode
radiofrequency ablation device, on the market in Europe -- showed a
one-month drop in BP of 14/10 to 20/7 mm Hg in clinical trials."
(5/19, Phend) reported, "Results of pilot studies on a variety of
novel renal sympathetic nerve ablation catheters are achieving in the
range of 28/10 to 32/15 mm Hg blood pressure reductions at one month,
researchers reported...at the EuroPCR meeting." In fact, "clinical
trials of the first such device -- the Symplicity single-electrode
radiofrequency ablation device, on the market in Europe -- showed a
one-month drop in BP of 14/10 to 20/7 mm Hg in clinical trials."
HeartWire
(5/19, Wood) reported, "Upwards of 20 other companies, according to Dr
Ron Waksman (Washington Hospital, DC), are busy developing competing
systems." The article went on to list the various systems, source of
data (animal or human), and the "BP drop, mm Hg."
(5/19, Wood) reported, "Upwards of 20 other companies, according to Dr
Ron Waksman (Washington Hospital, DC), are busy developing competing
systems." The article went on to list the various systems, source of
data (animal or human), and the "BP drop, mm Hg."
No comments:
Post a Comment